cystamine has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mezghrani, O | 1 |
| Tang, Y | 1 |
| Ke, X | 1 |
| Chen, Y | 1 |
| Hu, D | 1 |
| Tu, J | 1 |
| Zhao, L | 1 |
| Bourkaib, N | 1 |
| CICCARONE, P | 1 |
| MILANI, R | 1 |
| Iciek, MB | 1 |
| Rokita, HB | 1 |
| Wlodek, LB | 1 |
3 other studies available for cystamine and Cancer of Liver
| Article | Year |
|---|---|
Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cystamine; Doxoru | 2015 |
EFFECTS OF CYSTAMINE ON THE METABOLISM OF YOSHIDA HEPATOMA ASCITES CELLS IN VITRO.
Topics: Ascites; Carcinoma, Hepatocellular; Cystamine; Glucose; In Vitro Techniques; Liver Neoplasms; Metabo | 1964 |
Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2).
Topics: Allyl Compounds; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Division; Cystamine; Disulfi | 2001 |